SCIENCE
Our core focus is on fine-tuning the affinity of CAR T cells to selectively kill tumor cells, while sparing healthy cells to prevent toxicity and ensuring more natural, robust and long lasting activity of the CAR T cells. We engineer our CAR T cells to enable their distribution and activity to be monitored in real-time in patients during treatment.